Vendor, Lexington, KY
Enepret Incorporated
UEI P3KJFJJR58R4, CAGE 7T4R7
1 award and $0 obligated between July 16, 2026 and July 16, 2026, 100% under full and open competition, against 9.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93025C00020Definitive Contract, July 16, 2026, Full and Open Competition, 9 offers | National Institutes of Health NiaidNational Institutes of Health | Eo 14398; Adjuvant Discovery and Down-Selection for Vaccines Against Infectious and Immune-Mediated DiseasesNAICS 541714, PSC AN12 | $0 |
- Places of performance
- Kentucky
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards